Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immutep ADS Representing 10 Ord Shs IMMP

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to... see more

NDAQ:IMMP - Post Discussion

Immutep ADS Representing 10 Ord Shs > IMMP Price Target Alert: $6.00. Issued by Robert W. Baird
View:
Post by whytestocks on Jun 27, 2024 5:15pm

IMMP Price Target Alert: $6.00. Issued by Robert W. Baird

Just In: $IMMP IMMP Price Target Alert: $6.00. Issued by Robert W. Baird2024-06-27 08:00:12 ET Joel Beatty from Robert W. Baird issued a price target of $6.00 for IMMP on 2024-06-27 06:42:00. The adjusted price target was set to $6.00. At the time of the announcement, IMMP was trading at $2.77. The overall price target consensus is at $10.00...IMMP - IMMP Price Target Alert: $6.00. Issued by Robert W. Baird
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities